The Keto HDAC Myth — How One Paper Misled Millions for a Decade

A 2013 Science paper claimed beta-hydroxybutyrate (BHB), the primary ketone body produced during ketosis, was a potent histone deacetylase (HDAC) inhibitor with powerful epigenetic benefits — this claim became the foundation of the keto movement's health narrative

A devastating 2019 head-to-head comparison in Scientific Reports found that BHB shows no detectable HDAC inhibition in vitro or in vivo, while butyrate (a different molecule produced by gut bacteria) demonstrates robust HDAC-inhibiting activity

The bitter irony: ketogenic diets actually reduce colonic butyrate production by depleting fiber intake and diminishing butyrate-producing gut bacteria — the very diet designed to boost the "HDAC-inhibiting ketone" may be depleting the actual HDAC inhibitor

While BHB has legitimate benefits as an alternative fuel source and GPR109A receptor activator, the widespread claim that ketosis provides "epigenetic therapy" through HDAC inhibition appears to be scientifically unfounded